Literature DB >> 2446108

Characterization of rat T cell subset antigen by monoclonal antibody.

T Yamaki1, T Uede, Y Sugawara, T Wada, A Yamaguchi, Y Kokai, K Kikuchi.   

Abstract

6B2-B8 T cell hybridoma cells were used to immunize mice, and immune spleen cells were fused with NS/1 myeloma cells. One clone, designated RTH-7, reacted with 89.5% of rat thymocytes, 30.2% of rat spleen cells, and 42.3% of rat lymph node cells. The RTH-7 reacted with a subset of rat T cells but not with B cells. Double staining analysis demonstrated that RTH-7 stained a rat T cell subset distinct from R1-10B5-positive cells that were known to be equivalent to mouse Lyt-2. It was revealed that RTH-7 and W3/25 recognize different antigenic epitopes on the same molecule. The RTH-7 as well as W3/25 substantially inhibited the production of interleukin 2 by cells in mixed lymphocyte reaction and the lymphocyte proliferation induced by mixed lymphocyte reaction. The RTH-7 inhibited the lymphocyte proliferation induced by Con A whereas W3/25 failed to do so. The RTH-7 defined antigen has a molecular weight of 53,000 under reducing condition and 47,000 under nonreducing condition. The RTH-7 defined antigen showed a wide range of heterogeneity in pI (6.2-8.8). The associated molecule of approximate molecular weight of 27,000 was occasionally detected with the RTH-7 defined antigen in 6B2-B8 T cell hybridoma cells as well as peripheral T cells but not in thymocytes. Thus, RTH-7 detects a cell surface antigen of a functional T cell subset of rat origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446108     DOI: 10.1111/j.1348-0421.1987.tb03141.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection.

Authors:  K Hisatomi; T Isomura; E Tayama; K Tamehiro; M Ohashi; T Sato; K Kosuga; K Ohishi; Y Imai; K Itoh
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

2.  A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis.

Authors:  K Seto; M Abe; O Ohya; O Itakura; N Ishiguro; H Ikeda; A Wakisaka; T Yoshiki
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  A monoclonal antibody (8H3) that binds to rat T lineage cells and augments in vitro proliferative responses.

Authors:  Y Torimoto; M Kinebuchi; A Matsuura; K Kikuchi; T Uede
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

4.  A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.

Authors:  N Ishiguro; M Abe; K Seto; H Sakurai; H Ikeda; A Wakisaka; T Togashi; M Tateno; T Yoshiki
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

5.  Functional analysis of mononuclear cells infiltrating into tumors: establishment of a new system to obtain functionally active tumor-infiltrating cells.

Authors:  N Shijubo; T Uede; N Nomura; K Kikuchi
Journal:  Jpn J Cancer Res       Date:  1990-01

6.  Functional analysis of mononuclear cells infiltrating into tumors: establishment of T cell hybridomas exhibiting distinct interacting abilities with endothelial cells and extracellular matrix components.

Authors:  E Uno; K Kikuchi; I Saiki; T Uede
Journal:  Jpn J Cancer Res       Date:  1993-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.